← Back
Data updated: Mar 10, 2026
ALKERMES GAINESVILLE
Pharmaceuticals
ALKERMES GAINESVILLE is a generic drug manufacturer with 2 FDA-approved products.
1997
Since
2
Drugs
-
Trials
8
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
ISOSORBIDE MONONITRATE 2025-07-14
Labeling
ISOSORBIDE MONONITRATE 2025-07-14
Labeling
KETOPROFEN 2024-11-22
Labeling
KETOPROFEN 2024-11-21
Labeling
KETOPROFEN 2024-11-21
Labeling
KETOPROFEN 2024-11-21
Labeling
KETOPROFEN 2024-11-21
Labeling
KETOPROFEN 2024-11-21
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (0)
Discontinued (2)
Company Info
- First Approval
- 1997-12-10
- Latest
- 2002-03-18
- Applications
- 2